Mary Ann Lukas Selected Research

Carvedilol (Coreg)

1/2011	Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
9/2010	Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
6/2009	Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
5/2009	Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.
1/2008	Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.
1/2008	Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
11/2007	Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
10/2007	Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).
9/2007	Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
8/2007	Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Ann Lukas Research Topics

Disease

20	Heart Failure 11/2017 - 02/2003
8	Hypertension (High Blood Pressure) 01/2018 - 11/2004
8	Myocardial Infarction 11/2017 - 04/2005
5	Acute Coronary Syndrome 11/2017 - 10/2011
5	Left Ventricular Dysfunction 01/2011 - 04/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2008 - 11/2004
4	Diabetes Mellitus 01/2008 - 11/2004
3	Stroke (Strokes) 09/2014 - 03/2007
3	Insulin Resistance 05/2009 - 11/2004
2	Amyloidosis 01/2022 - 01/2022
2	Atherosclerosis 09/2014 - 10/2011
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2011 - 04/2005
2	Systolic Heart Failure 01/2011 - 09/2007
2	Cardiomyopathies (Cardiomyopathy) 06/2009 - 03/2007
2	Atrial Fibrillation 04/2005 - 05/2004
1	Renal Insufficiency (Renal Failure) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Amyloid Plaque 01/2022
1	Immunoglobulin Light-chain Amyloidosis 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017
1	Diarrhea 09/2014
1	Inflammation (Inflammations) 09/2014
1	Chronic Renal Insufficiency 01/2011
1	Kidney Diseases (Kidney Disease) 01/2011
1	Dyslipidemias (Dyslipidemia) 05/2009
1	Hypotension (Low Blood Pressure) 10/2007
1	Infarction (Infarctions) 10/2007
1	Heart Arrest (Cardiac Arrest) 10/2007
1	Diabetic Coma 08/2007
1	Gangrene 08/2007
1	Diabetic Foot 08/2007
1	Weight Gain 07/2007
1	Shock 06/2007
1	Unstable Angina 03/2007
1	Albuminuria 12/2005
1	Cardiac Arrhythmias (Arrythmia) 04/2005
1	Ischemia 04/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2004

Drug/Important Bio-Agent (IBA)

24	Carvedilol (Coreg)FDA LinkGeneric 01/2011 - 02/2003
10	Metoprolol (Toprol-XL)FDA LinkGeneric 05/2009 - 11/2004
5	darapladibIBA 11/2017 - 10/2011
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2017 - 10/2011
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2008 - 04/2005
2	dezamizumabIBA 01/2022 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2022
2	Monoclonal AntibodiesIBA 01/2022 - 01/2022
2	miridesapIBA 01/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2007
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2017 - 06/2009
2	Insulin (Novolin)FDA Link 05/2009 - 07/2007
2	Antihypertensive Agents (Antihypertensives)IBA 05/2009 - 12/2005
2	Angiotensin Receptor AntagonistsIBA 01/2008 - 12/2005
2	Amiodarone (Amiodarona)FDA LinkGeneric 06/2007 - 04/2005
1	Serum Amyloid P-ComponentIBA 01/2022
1	AntibodiesIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2017
1	CytokinesIBA 10/2017
1	antineoplaston A10 (A 10)IBA 10/2017
1	Troponin IIBA 10/2017
1	C-Reactive ProteinIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Interleukin-6 (Interleukin 6)IBA 10/2017
1	TabletsIBA 10/2011
1	Lisinopril (Prinivil)FDA LinkGeneric 09/2010
1	Triglycerides (Triacylglycerol)IBA 05/2009
1	C-PeptideIBA 05/2009
1	LipidsIBA 05/2009
1	Hemoglobin AIBA 01/2008
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2004
1	Digoxin (Digitek)FDA LinkGeneric 05/2004

Therapy/Procedure

11	Therapeutics 01/2011 - 02/2003
3	Glycemic Control 01/2008 - 11/2004
2	Electric Countershock (Cardioversion) 04/2005 - 05/2004
1	Transplantation 01/2022
1	Drug Therapy (Chemotherapy) 06/2009